Transformation of rat cells by DNA of human adenovirus 5

doi:10.1016/0042-6822(73)90163-3

Virology

Volume 54, Issue 2, August 1973, Pages 536-539

https://doi.org/10.1016/0042-6822(73)90163-3 Get rights and content

Abstract

Primary rat embryo and baby rat kidney cells have been transformed by human adenovirus 5 DNA. Transforming activity was resistant to heating (1 hr at 56 °C), and to pronase, but was sensitive to DNase. The efficiency of transformation was approximately 1 transformed focus/μg DNA.

References (11)

F.L. Graham et al.
Virology
(1973)
A.J. van der Eb et al.
Biochim. Biophys. Acta
(1969)
P. Bourgaux et al.
Virology
(1965)
S.A. Aaronson et al.
Virology
(1970)
J.P. Burnett et al.

There are more references available in the full text version of this article.

Cited by (437)

Biodegradable calcium phosphate nanoparticles for cancer therapy
2020, Advances in Colloid and Interface Science
Calcium phosphate is the inorganic mineral of hard tissues such as bone and teeth. Due to their similarities to the natural bone, calcium phosphates are highly biocompatible and biodegradable materials that have found numerous applications in dental and orthopedic implants and bone tissue engineering. In the form of nanoparticles, calcium phosphate nanoparticles (CaP’s) can also be used as effective delivery vehicles to transfer therapeutic agents such as nucleic acids, drugs, proteins and enzymes into tumor cells. In addition, facile preparation and functionalization of CaP’s, together with their inherent properties such as pH-dependent solubility provide advantages in delivery and release of these bioactive agents using CaP’s as nanocarriers. In this review, the challenges and achievements in the intracellular delivery of these agents to tumor cells are discussed. Also, the most important issues in the design and potential applications of CaP-based biominerals are addressed with more focus on their biodegradability in tumor microenvironment.
Positive allosteric modulation of native and recombinant GABA<inf>A</inf> receptors by hops prenylflavonoids
2019, European Journal of Pharmacology
Hops are a major component of beer that is added during brewing. In addition to its wide range of bioactivity, it exhibits neuroactive properties as a sedative and sleeping aid. The compounds responsible for this activity are yet to be revealed and understood in terms of their pharmacological properties. Here we evaluated the potential of several hops flavonoids in modulating the GABAergic activity and assessed their selectivity to GABA_A receptors subtypes. GABA-potentiating effects were measured using [³H]ethynylbicycloorthobenzoate (EBOB) radioligand binding assay in native and recombinant α1β3γ2, α2β3γ2 and α6β3δ receptors expressed in HEK293 cells. Flumazenil sensitivity of GABA-potentiating effects and [³H]Ro 15-4513 binding assay were used to examine the flavonoids binding to benzodiazepine site. The prenylflavonoids xanthohumol (XN), isoxanthohumol (IXN) and 8-prenylnaringenin (8PN) potentiated GABA-induced displacement of [³H]EBOB binding in a concentration-dependent manner. The IC₅₀ for this potentiation in native GABA_A receptors were 29.7 µM, 11.6 µM, 7.3 µM, respectively. In recombinant receptors, the sensitivity to prenylflavonoid potentiation of GABA-induced displacement of [³H]EBOB binding followed the order α6β3δ > α2β3γ2 > α1β3γ2 with the strongest inhibition observed by 8PN in α6β3δ (IC₅₀ = 3.6 μM). Flumazenil had no significant effect on the prenylflavonoid-induced displacement of [³H]EBOB binding and [³H]Ro 15-4513 displacement from native GABA_A receptors was only detected at high micromolar concentrations (100 µM). We identified potent prenylflavonoids in hops that positively modulate GABA-induced responses in native and αβγ/δ recombinant GABA_A receptors at low micromolar concentrations. These GABAergic modulatory effects were not mediated via the high-affinity benzodiazepine binding site.
In vivo methods for acute modulation of gene expression in the central nervous system
2018, Progress in Neurobiology
Citation Excerpt :
Thus, the support of specific carriers or chemical/physical stimulation is often necessary to increase the efficiency of the transfection process. Although highly efficient, acute introduction of DNA into mammalian cells in vitro was achieved a long time ago (Graham and van der Eb, 1973), for the last four decades, scientists have struggled to increase the efficiency of this process in vivo (Crystal, 2014). For example, circulating nucleic acids for transfection have a very short half-life in vivo because they are degraded by circulating nucleases in the blood.
Accurate and timely expression of specific genes guarantees the healthy development and function of the brain. Indeed, variations in the correct amount or timing of gene expression lead to improper development and/or pathological conditions. Almost forty years after the first successful gene transfection in in vitro cell cultures, it is currently possible to regulate gene expression in an area-specific manner at any step of central nervous system development and in adulthood in experimental animals in vivo, even overcoming the very poor accessibility of the brain. Here, we will review the diverse approaches for acute gene transfer in vivo, highlighting their advantages and disadvantages with respect to the efficiency and specificity of transfection as well as to brain accessibility. In particular, we will present well-established chemical, physical and virus-based approaches suitable for different animal models, pointing out their current and future possible applications in basic and translational research as well as in gene therapy.
Transfection
2017, Basic Science Methods for Clinical Researchers
Over the last 30 years, the transfection of DNA or RNA into mammalian cells has evolved into an ever more sophisticated research tool for the investigation of gene expression and protein function. Transfection is used to describe the process of introducing foreign nucleic acid into a cell. Here we aim to give an overview of commonly used transfection methods, their application, and relative advantages and disadvantages. We will then present a current transfection protocol as a worked example and highlight practical issues such as how to troubleshoot and optimize an existing transfection protocol.
CD44 regulates cell proliferation, migration, and invasion via modulation of c-Src transcription in human breast cancer cells
2015, Cellular Signalling
CD44 was recently identified as a cancer initiation marker on the cell membrane. The cytoplasmic tail of CD44 is known to bind ERM (ezrin, radixin, moesin) proteins, cytoskeletal proteins like ankyrin, and the non-receptor tyrosine kinase c-Src. CD44 transmits its oncogenic signaling via c-Src and its downstream effectors. To investigate the role of CD44 in breast cancer cells, we generated CD44 knock-down cells via retroviral delivery of shRNA against CD44. We found that silencing of CD44 decreased the proliferation, migration, and invasion of breast cancer cells. The expression and activity of cell migration-related proteins, including c-Src, paxillin, and FAK were decreased by CD44 silencing. We also found that the c-Jun protein level was negatively regulated via induction of a GSK-3β-dependent degradation pathway in CD44 knock-down cells. The expression level of Sp1, a target gene product of c-Jun, was also decreased in these cells. Finally, CD44 knock-down suppressed both mRNA and protein levels of c-Src and its downstream MAPK pathway as a result of down-regulation of Sp1 as a transcription factor for c-Src. Collectively, these results indicate that biological changes induced by CD44 silencing are mediated by cumulative down-regulation of c-Jun, Sp1, and c-Src in human breast cancer cells.
FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells
2024, International Journal of Oncology

View all citing articles on Scopus

View full text

Transformation of rat cells by DNA of human adenovirus 5

Abstract

Virology

Biochim. Biophys. Acta

Virology

Virology